Koyfin Home > Directory > Health Care > Aimmune Therap > Total Equity

Aimmune Therap Total Equity Chart (AIMT)

Aimmune Therap annual/quarterly Total Equity from 2014 to 2020.
  • Aimmune Therap Total Equity for the quarter ending June 06, 2020 was $180m a 15.10% increase of 27m year over year
  • Aimmune Therap Total Equity for the last 12 months ending June 06, 2020 was $180m a 15.10% increase of 27m year over year
  • Aimmune Therap Annual Total Equity for 2019 was $104m a -187.38% decrease of -195m from 2018
  • Aimmune Therap Annual Total Equity for 2018 was $299m a 40.52% increase of 121m from 2017
  • Aimmune Therap Annual Total Equity for 2017 was $178m a -60.83% decrease of -108m from 2016
Other Balance Sheet Metrics:
  • Aimmune Therap Total Assets for the quarter ending September 09, 2018 was $287m a 28.01% increase of 81m year over year
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
View Chart On Koyfin

Quarterly AIMT Total Equity Data

06/2020$180m
03/2020$235m
12/2019$104m
09/2019$153m
06/2019$205m
03/2019$256m
12/2018$299m
09/2018$247m
06/2018$288m
03/2018$329m

Annual AIMT Total Equity Data

2019$104m
2018$299m
2017$178m
2016$286m
2015$206m
2014$1m
2013$12m